ClinVar Miner

Submissions for variant NM_001083962.2(TCF4):c.1876C>T (p.Arg626Ter)

dbSNP: rs1131691735
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000493014 SCV000582727 pathogenic not provided 2023-10-04 criteria provided, single submitter clinical testing Not observed in large population cohorts (gnomAD); Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 46 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); This variant is associated with the following publications: (PMID: 22045651, 22460224, 29604340, 31440721)
Center for Human Genetics, Inc, Center for Human Genetics, Inc RCV000660298 SCV000782335 likely pathogenic Pitt-Hopkins syndrome 2016-11-01 criteria provided, single submitter clinical testing
Invitae RCV000660298 SCV000819174 pathogenic Pitt-Hopkins syndrome 2022-09-30 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 430016). This premature translational stop signal has been observed in individual(s) with Pitt–Hopkins Syndrome (PMID: 22045651). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg626*) in the TCF4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TCF4 are known to be pathogenic (PMID: 18728071, 22045651).
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV000493014 SCV001446521 pathogenic not provided 2020-10-23 criteria provided, single submitter clinical testing
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics RCV000660298 SCV002762860 pathogenic Pitt-Hopkins syndrome 2020-12-23 criteria provided, single submitter research A heterozygous nonsense variation in exon 19 of the TCF4 gene that results in a stop codon and premature truncation of the protein at codon 728 was detected. The observed variant c.2182C>T (p.Arg728Ter) has not been reported in the 1000 genomes and gnomAD databases. The in silico prediction of the variant is damaging by MutationTaster2. The reference codon is conserved across species. Segregation analysis showed this variant to be de novo. In summary, the variant meets our criteria to be classified as a pathogenic variant.
Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues RCV000660298 SCV003035475 pathogenic Pitt-Hopkins syndrome 2022-04-05 criteria provided, single submitter clinical testing
Ambry Genetics RCV003159600 SCV003882800 pathogenic Inborn genetic diseases 2023-02-14 criteria provided, single submitter clinical testing The c.1876C>T (p.R626*) alteration, located in exon 18 (coding exon 17) of the TCF4 gene, consists of a C to T substitution at nucleotide position 1876. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 626. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been identified in multiple individuals with clinical features of Pitt-Hopkins syndrome (Liu, 2018; Whalen, 2012). Based on the available evidence, this alteration is classified as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.